Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells
- First Online:
- Cite this article as:
- Decaris, M.L., Lee, C.I., Yoder, M.C. et al. Angiogenesis (2009) 12: 303. doi:10.1007/s10456-009-9152-6
- 571 Downloads
Therapeutic angiogenesis is a promising strategy to promote the formation of new or collateral vessels for tissue regeneration and repair. Since changes in tissue oxygen concentrations are known to stimulate numerous cell functions, these studies have focused on the oxygen microenvironment and its role on the angiogenic potential of endothelial cells. We analyzed the proangiogenic potential of human endothelial colony-forming cells (hECFCs), a highly proliferative population of circulating endothelial progenitor cells, and compared outcomes to human dermal microvascular cells (HMVECs) under oxygen tensions ranging from 1% to 21% O2, representative of ischemic or healthy tissues and standard culture conditions. Compared to HMVECs, hECFCs (1) exhibited significantly greater proliferation in both ischemic conditions and ambient air; (2) demonstrated increased migration compared to HMVECs when exposed to chemotactic gradients in reduced oxygen; and (3) exhibited comparable or superior proangiogenic potential in reduced oxygen conditions when assessed using a vessel-forming assay. These data demonstrate that the angiogenic potential of both endothelial populations is influenced by the local oxygen microenvironment. However, hECFCs exhibit a robust angiogenic potential in oxygen conditions representative of physiologic, ischemic, or ambient air conditions, and these findings suggest that hECFCs may be a superior cell source for use in cell-based approaches for the neovascularization of ischemic or engineered tissues.
KeywordsAngiogenesis Endothelial cells Endothelial progenitor cells Neovascularization
Cardiovascular diseases caused by atherosclerotic narrowing or occlusion of arteries remain the leading cause of morbidity and mortality in developed countries . Although percutaneous revascularization and bypass surgery provide a means to restore blood flow to ischemic tissues, not all patients with symptomatic ischemic diseases are suitable candidates for these interventions. Therapeutic angiogenesis is a promising treatment option for these patients. A number of new potential therapies are under investigation to revitalize ischemic tissues including the delivery of recombinant angiogenic growth factors and cytokines, the use of gene therapy to deliver plasmid DNA encoding for proangiogenic factors, and the implantation of proangiogenic biomaterials [2, 3, 4]. Despite promising results, these therapies suffer from limitations including the dependence of host cells to respond to these inductive cues, reliance upon the kinetics and duration of protein presentation for efficacy, and the potential inability of donor cells to adjust to the hypoxic environment of the damaged tissue. Cell-based approaches to therapeutic angiogenesis may provide a viable alternative for improved neovascularization by transplanting cells that directly participate or indirectly promote the formation of new vessels.
Therapeutic angiogenesis may be achieved through a cell-based approach. Compared to pharmacological strategies [5, 6], the transplant of cells of the endothelial lineage can accelerate this process by formation of new capillaries. Local implantation of terminally differentiated endothelial cells, both microvascular such as human dermal microvascular cells (HMVECs) and umbilical vein-derived endothelial cells (HUVECs), has yielded functional vessels in rodent models, but these neovessels only survive for a short period of time [7, 8, 9, 10, 11, 12]. Alternatively, endothelial progenitor cells (EPCs) represent a source of endothelial cells that may be isolated from adult peripheral or umbilical cord blood and possess high proliferative potential; thus, eliminating the challenges in expanding autologous HMVECs for graft endothelialization or transplantation [13, 14, 15, 16, 17]. Endothelial colony-forming cells (ECFCs) represent the only EPCs that display clonal proliferative potential, high levels of telomerase, form de novo vessels upon implantation in vivo, and spontaneously anastomose with the host vasculature . However, the angiogenic properties of ECFCs in ischemic or physiologic oxygen microenvironments remain to be fully explored.
The oxygen microenvironment is a potent stimulator of cell behavior. Oxygen tension throughout the body ranges from nearly anoxic in cartilage and ischemic cardiac or cerebral tissues to approximately 13% in arteries . Microvascular endothelial cells from various sources exhibit significant differences in their proliferative, migratory, and tubule/vessel-forming capacity as a result of changes in environmental oxygen tension [20, 21, 22]. Endothelial cells may also increase the production of proangiogenic growth factors including vascular endothelial growth factor (VEGF) and collagenases such as MMP-9 in response to hypoxic conditions [23, 24, 25], each of which play an important role in the process of cell-mediated vessel formation.
We hypothesized that local oxygen tension would affect the vessel-forming behavior of cells of the endothelial lineage, and that endothelial cells from different sources may exhibit different responses to hypoxic conditions. To explore this hypothesis, we compared the proangiogenic potential of human ECFCs (hECFCs) to HMVECs in controlled oxygen tensions in vitro and demonstrated that hECFCs possess comparable or enhanced proangiogenic potential at all oxygen tensions studied when compared to HMVECs. Thus, hECFCs are likely a superior cell source for use in cell-based approaches focused on the neovascularization of ischemic or engineered tissues.
Materials and methods
Human umbilical cord blood ECFCs were isolated using a protocol approved by the Institutional Review Board of the Indiana University School of Medicine as previously described . The adherent ECFCs were cultured in T-75 culture flasks (Nunc) coated with a layer of 5 μg/cm2 rat tail collagen I (BD Biosciences) in EGM®-2 media supplemented with Lonza’s SingleQuot supplement (hydrocortisone, gentamycin, human VEGF, human fibroblast growth factor (FGF), human epidermal growth factor (EGF), human insulin-like growth factor (IGF), and heparin) and supplemented with 10% fetal bovine serum (FBS, JR Scientific), 1% penicillin/streptomycin, and 0.1% amphotericin β (Mediatech). Adult dermal HMVECs were received in cryogenic ampoules (Clonetics® HMVEC-dAd-Adult Human Dermal Microvascular Endothelial Cells, Lonza) and cultured in EGM®-2MV Microvascular Endothelial Cell Growth Medium-2 supplemented with the Bulletkit supplement (5% FBS, hydrocortisone, gentamycin, human VEGF, human FGF, human EGF, human IGF, and ascorbic acid). Both hECFCs and HMVECs were maintained in standard CO2 incubators at 37°C prior to experimentation.
Controlling the oxygen microenvironment
Experimental endpoints, assays, and oxygen tensions employed
Oxygen tension applied (%)
≪1, 4, 8, 12, 16, and 21
Boyden chamber assay
1, 5, and 21
Matrigel tubule formation assay
1, 5, and 21
Caspase 3/7 activity
1, 5, and 21
1, 5, and 21
Western blotting for HIF-1α
1, 5, and 21
The role of the oxygen microenvironment on hECFCs and HMVECs mitogenic potential was assessed by quantitating cellular proliferation when cultured in varied oxygen conditions (≪1% representing near anoxic conditions, 4, 8, 12, 16, and 21% O2). hECFCs and HMVECs were seeded in complete media (7,500 cells/cm2 in EGM-2MV with 5% FBS) in 6-well culture dishes and allowed to attach overnight. To initially determine the optimal growth substrate for each population, hECFCs and HMVECs were seeded on wells coated with 5 μg/cm2 rat tail collagen or on tissue culture plastic. Subsequent experiments were performed with hECFCs grown on collagen and HMVECs grown on plastic. After attachment, media was changed and plates were placed in the desired oxygen tension for 72 h. Each well was rinsed with Hank’s Balanced Salt Solution (Gibco) and cells were trypsinized and scraped from the well surfaces prior to counting. Cell counts of each well were performed in triplicate with a Z1 Dual Coulter Counter (Beckman).
Human endothelial colony-forming cells and HMVEC migration at various oxygen tensions were evaluated using a modified Boyden chamber assay as previously described . Briefly, 24-well fluoroblok transwells (3 μm pore size, BD Biosciences) were coated with a thin layer of gelatin solution (0.1% bovine skin gelatin, Sigma). Cells (1 × 105 cells/well) were seeded on the top of the transwells in 300 μL serum-free growth factor deficient EGM-2MV supplemented with 0.1% fatty acid-free BSA (Sigma). Transwells were then placed over complete EGM-2 containing 10% FBS to create a positive chemotactic gradient, while serum-free media served as the negative control. Plates were then placed in hypoxia chambers or standard CO2 incubators for 24 h. Cells that migrated to the bottom of the transwell were stained via incubation with calcein AM (3 μg/mL in HBSS, Anaspec) for 30 min, and fluorescence was quantitated using a microplate reader (Synergy HTTR) at 485/530 nm.
The tubulogenic capacity of each cell type was determined when cultured in varying oxygen conditions. Briefly, Matrigel (150 μL, BD Biosciences) was pipetted into 24-well plates and allowed to gel at 37°C for 1 h. Cells were seeded on Matrigel at 2 × 104 cells/cm2 in 500 μL of complete EGM-2MV supplemented with 5% FBS. Cells were placed in the appropriate oxygen microenvironment as described above, cultured for 6 h, and images of tubule formation were captured using a Nikon Eclipse TE2000-U and SpotRT digital camera.
Acetylated LDL uptake
Acetylated low density lipoprotein labeled with 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL) (Biomedical Technologies) was used to characterize ac-LDL uptake by hECFCs and HMVECs at varying oxygen tensions. Cells were seeded in 6-well plates at 7,500 cells/cm2 as described above and placed in 1, 5, or 21% oxygen for 72 h. Cells were then incubated for 4 h in complete EGM-2MV + 5% FBS containing 10 μg/mL of DiI-Ac-LDL at their respective oxygen tensions followed by multiple media rinses. Images of Ac-LDL uptake were captured by fluorescence microscopy using a Nikon Eclipse TE2000-U.
The apoptotic response of hECFCs and HMVECs to different oxygen conditions was determined by quantitating caspase 3/7 activity (Caspase-Glo 3/7 Assay, Promega). Cells were seeded (5 × 103 cells/well) on Nunclon Surface 96-well white cell culture plates (Nunc) in 100 μL complete EGM-2MV containing 5% FBS. After 24 h, nonadherent cells were rinsed away with PBS, media was replaced, and the 96-well plates were placed in hypoxia chambers or standard CO2 incubators at 37°C for an additional 24 h. Plates were then equilibrated to room temperature and 100 μL of the luminescent caspase substrate/buffer mix was added to each well. Plates were agitated at 400 rpm for 30 s and allowed to sit for 60 min. Luminescence of each well was quantitated using a microplate reader. Additional wells of cells were also seeded in order to normalize the caspase 3/7 quantities to cell number. 100 μL of passive lysis buffer (Promega) was applied to each additional well at the conclusion of the assay and cell DNA content was determined following the manufacturer’s instructions (Quant-iT PicoGreen dsDNA Assay Kit, Invitrogen).
Western blot analysis
Human endothelial colony-forming cells and HMVECs were seeded on 6 well plates (5 × 104 cells/cm2) and allowed to attach overnight. The plates were then placed in hypoxia chambers, standard cell culture incubators, or cultured in ambient air with or without the presence of the Hypoxia Inducible Factor 1-alpha (HIF-1α) stabilizer CoCl2 (100 μm, Sigma) for 4 h, removed and rinsed with PBS, followed by total protein collection in 4x sample buffer (20% glycerol, 4% SDS, 0.05% bromophenol blue, 160 mM Tris–HCl, and 200 mM DTT). Protein concentration was determined using the Amido Black method, a solid-phase method for the quantitation of protein in the presence of sodium dodecyl sulfate and other interfering substances . 20–40 μg of protein per sample were resolved in 4–20% Tris–HCl acrylamide gels and transferred onto 0.2 mm nitrocellulose. Blots were blocked in 0.5% nonfat milk in Tris-buffered saline with 0.05% Tween-20 (TBST) for 2 h and probed with rabbit anti-human polyclonal antibody to HIF-1α (1:400 in blocking buffer; Cayman Chemical, 10006421) overnight at 4°C. Membranes were washed and probed with horseradish peroxidase-conjugated secondary antibodies at 1:2,500 (Cayman) and reactive bands were visualized using enhanced chemiluminescence and X-ray film. Membranes were then stripped and blocked a second time with 5% nonfat milk in TBST for 1 h and probed with α-tubulin (11H10) Rabbit monoclonal antibody (1:1,000 in blocking buffer; Cell Signaling, 2125S) overnight at 4°C. Secondary antibodies and visualization were carried out as previously stated.
The values on the graphs represent means and standard error unless otherwise stated. Statistical analysis was performed using a paired Student’s t-test. P values less than 0.05 were considered statistically significant.
Population doubling times of hECFC and HMVEC cultured in varied oxygen tensions
Oxygen tension (%)
hECFC doubling time (days)
HMVEC doubling time (days)
3.12 ± 0.15*
9.00 ± 0.81
1.85 ± 0.03*
2.40 ± 0.07
1.54 ± 0.02
1.57 ± 0.08
1.51 ± 0.03
1.40 ± 0.04
1.40 ± 0.04*
2.15 ± 0.02
1.56 ± 0.03*
3.58 ± 0.31
Acetylated LDL uptake
hECFCs respond to changes in oxygen tension
Human endothelial colony-forming cells and HMVECs were studied using in vitro angiogenesis assays under varying oxygen tensions to test our hypothesis that hypoxic conditions could alter the proangiogenic potential of these cells. hECFCs performed as well or better than HMVECs when characterizing their proangiogenic potential, with particular emphasis on proliferation, migration, and tubulogenesis. These findings indicate that endothelial cell populations respond differently to hypoxic conditions and suggest that hECFCs may be a superior population for the neovascularization of ischemic or engineered tissues.
Endothelial colony-forming cells represent a highly proliferative population of circulating endothelial cells that have recently been distinguished from other EPC populations by their lack of hematopoietic surface markers and their ability to promote vasculogenesis [18, 30, 31]. Much like other progenitor cell populations, the number and function of circulating ECFCs diminishes with age and deteriorating health but increases after acute myocardial infarction. These data suggest a possible link between the presence of these cells in the circulation, cardiovascular health, and ongoing repair [32, 33]. Compared to terminally differentiated endothelial cells, the ability to isolate these cells noninvasively from cord blood provides a distinct advantage over skin biopsy.
We observed a strong correlation between oxygen tension and three hallmarks of angiogenesis: cell proliferation, migration, and tubule formation. hECFCs exhibited a significantly greater proliferative capacity compared to HMVECs at low oxygen tensions in vitro (≪1% and 4% O2), simulating conditions found within hypoxic tissues in vivo. The increased proliferative potential observed with hECFCs under hypoxic conditions suggests the potential for accelerating vessel formation. Furthermore, these data suggest that fewer cells would be required for transplant in the clinical setting to form functional vessels compared to existing methods using HMVECs. Our results also confirm the increased proliferative capacity of hECFCs compared to HMVECs in ambient oxygen typically associated with cell culture (21% O2). This proliferative ability effectively reduces the time required to achieve sufficient cell numbers for transplantation to treat ischemic tissues or incorporate within a tissue-engineered scaffold. Finally, the proliferative capacity of hECFCs over a wide range of oxygen tensions differed from that of HMVECs. HMVEC proliferation peaked near physiological oxygen tensions observed in the arterial system . In contrast, hECFC proliferation plateaued at 8% O2 and remained constant at the higher levels assessed. These data suggest that changes in the oxygen microenvironment may have less of an effect on the proliferative capacity of hECFCs compared to HMVECs.
Human endothelial colony-forming cells also appeared to possess a higher level of sensitivity to a chemotactic gradient compared to HMVECs when quantitating cell migration at reduced oxygen tensions (1 and 5% O2). Measurements of fluorescence intensity revealed increased hECFC migration compared to HMVECs in the presence of a chemotactic gradient. These data suggest that hECFCs may be capable of enhanced localization to sites of hypoxic stimuli in vivo when compared to HMVECs. Further, the reduced migration observed with hECFCs in the absence of a cytokine gradient suggests that hECFCs may remain at the transplant site to participate in capillary formation and avoid migration away from the desired tissue.
Regardless of oxygen tension, we observed robust tubule formation and uptake of acetylated LDL for both hECFCs and HMVECs. Both cell populations formed capillary-like structures at all oxygen levels tested. However, we detected distinct differences in tubule morphology between cell types at the same oxygen tension, with hECFCs forming smooth and more well-rounded tubules compared to HMVECs. Similar to reports by others, cell aggregation limited the accuracy of quantitation of cells participating in tubular structures . Although it is widely accepted that tubulogenesis and LDL uptake are insufficient to characterize the endothelial lineage of different progenitor cell populations , these assays aid in assessing the capacity of an endothelial cell to maintain a functional phenotype when exposed to harmful environmental stimuli such as hypoxia. We have shown that hECFCs cultured in oxygen tensions representative of ischemia exhibit characteristic behavior similar to mature microvascular cells residing within a hypoxic environment.
Our findings suggest that hECFCs are less sensitive to apoptotic stimuli than HMVECs. While an approximately 3.5-fold increase in HMVEC caspase activity was observed at 1% O2 compared to ambient conditions, hECFC caspase activity increased by only approximately twofold. While hECFCs did express higher baseline caspase levels than HMVECs when cultured under ambient conditions, both cell types expressed nearly identical caspase concentrations under conditions approximating those within hypoxic tissue. These data suggest that both cell types may have similar survivability when transplanted into ischemic sites in vivo. These data are in agreement with prior studies by Ingram et al.  that reported increased ECFC apoptosis upon the introduction of peroxide-mediated oxidative stress and simulation of vascular injury. It is likely that the culture of cells in reduced oxygen may initiate oxygen-responsive cues similar to those stimulated by small molecules, and the presence or magnitude of these cues directly impact apoptosis.
In order to probe the mechanism for differences in proangiogenic potential, we investigated the upregulation of HIF-1α by each cell type in response to oxygen tension. Our data revealed a stark upregulation of this potent transcription factor in reduced oxygen (1% O2) for both cells, while little to no expression was observed at higher oxygen tensions. These results differ from earlier studies that reported only minor shifts in HIF-1α expression across conditions in EPCs cultured under similar oxygen levels . HIF-1α upregulation signals the increase in transcription of growth factors such as VEGF that may, in turn, enhance endothelial cell proliferation and migration. However, we failed to detect significant increases in VEGF secretion by hECFCs compared to HMVECs in 1, 5, or 21% O2 using ELISA (data not shown). The transplant of EPCs genetically engineered to overexpress HIF-1α has demonstrated increased proliferation, migration, and capacity to promote reperfusion in vivo . Our observation of comparable HIF upregulation and VEGF secretion in both cell types stimulated by local oxygen conditions excludes the contribution of endogenous proangiogenic molecules as the sole mechanism for the increased proliferative capacity observed with hECFCs. Additional studies that focus on the molecular differences in cell division are warranted to explain these findings.
These data demonstrate that the proangiogenic response of cells of the endothelial lineage is highly dependent upon local oxygen tension and may differ in response to varying oxygen levels. Further investigation of the mechanism(s) responsible for these findings may reveal the optimal endothelial cell populations and conditions for the neovascularization of ischemic sites.
These studies were supported by a pilot grant from the Center of Excellence in Translational Human Stem Cell Research (NIH grant # P50-HL085036) and the NIH T32 Molecular Imaging Training Grant (NIH grant # EB003827). The authors thank Damian Genetos, PhD, for experimental assistance.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.